Victrex plc (LON:VCT) has earned an average rating of “Hold” from the thirteen research firms that are currently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is GBX 2,526.11 ($33.01).

A number of brokerages recently issued reports on VCT. Morgan Stanley downgraded Victrex to an “underweight” rating and lowered their price target for the stock from GBX 2,500 ($32.67) to GBX 2,300 ($30.05) in a research report on Friday. Peel Hunt restated an “add” rating on shares of Victrex in a research report on Wednesday, July 25th. UBS Group restated a “buy” rating and issued a GBX 3,600 ($47.04) price target (up from GBX 3,300 ($43.12)) on shares of Victrex in a research report on Thursday, October 4th. Citigroup restated a “neutral” rating on shares of Victrex in a research report on Tuesday, July 17th. Finally, Barclays restated an “underweight” rating and issued a GBX 2,380 ($31.10) price target (up from GBX 2,300 ($30.05)) on shares of Victrex in a research report on Tuesday, July 24th.

In other Victrex news, insider Jakob Sigurdsson bought 3,250 shares of Victrex stock in a transaction on Wednesday, July 25th. The shares were acquired at an average price of GBX 3,072 ($40.14) per share, for a total transaction of £99,840 ($130,458.64). Over the last 90 days, insiders purchased 3,262 shares of company stock valued at $10,021,700.

Shares of LON VCT traded down GBX 126 ($1.65) during midday trading on Wednesday, reaching GBX 2,618 ($34.21). 981,245 shares of the stock traded hands, compared to its average volume of 274,177. Victrex has a one year low of GBX 1,826 ($23.86) and a one year high of GBX 2,772 ($36.22).

About Victrex

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.

Recommended Story: How are Outstanding Shares Different from Authorized Shares?

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with's FREE daily email newsletter.